[1] Matt KA,Carter RA,Boeckh M,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors[J].Blood,2002,100(13):4358-4366. [2] Fukuda T,Boeckh M,Carter RA,et al.Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning[J].Blood,2003,102(3):827-833. [3] Mart KA,Patterson T,Denning D.Aspergillosis.Pathogenesis,clinical manifestations,and therapy[J].Infect Dis Clin North Am,2002,16(4):875-894. [4] Denning DW.Invasive aspergillosis[J].Clin Infect Dis,1998,26(4):781-803. [5] Large JP.Aspergillus fumigatus and aspergillosis[J].Clin Microbiol Rev,1999,12(2):310-350. [6] Stevens DA.Vaccinate against aspergillosis! A call to arms of the immune system[J].Clin Infect Dis,2004,38(8):1131-1136. [7] Hosponthal DR,Kwon-Chung KJ,Bennett JE.Concentrations of airborne Asporgillus compared to the incidence of invnsive aspergillosis:lack of correlation[J].Med Mycol,1998,36 (3):165-168. [8] Cenci E,Mencacci A,Bacci A,et al.T cell vaccination in mice with invasive pulmonary aspergillosis[J].J Immunol,2000,165(1):381-388. [9] Cenci E,Mencacci A,Fe dC,et el.Cytokine-and T helpor-dependent lung mucosal immunity in mice with invnsive pulmonary aspergillosis[J].J Infect Dis,1998,178(6):1750-1760. [10] Hebart H,Bellinger C,Fisch P,et al.Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies[J].Blood,2002,100(13):4521-4528. [11] Bozza S,Gaziano R,Lipford GB,et al.Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants[J].Microbes Infect,2002,4(13):1281-1290. [12] Stanzani M,Orcinolo E,Lewis R,et al.Aspergillus fumigatus suppresses the human cellular immune response via gliotoxinmediated apoptosis of rnonocytes[J].Blood,2005,105 (6):2258-2265. |